BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:53 PM
 | 
Jun 04, 2008
 |  BC Extra  |  Company News

FDA investigating TNF inhibitors

FDA is investigating about 30 reports of cancer in children and young adults treated with anti-TNF drugs for juvenile idiopathic arthritis (JIA), Crohn's disease and other diseases. The reports, submitted to FDA's Adverse Event Reporting System between 1998 and April 29, 2008, showed that half the cancers were lymphomas, including both Hodgkin's and non-Hodgkin's lymphomas. Three TNF inhibitors are approved in the...

Read the full 289 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >